This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

*** Editor’s Pick

RCT shows Ide-cel effective in refractory or relapsed multiple myeloma
RCT shows Ide-cel effective in refractory or relapsed multiple myeloma
Study evaluates the effectiveness and safety of prescribing pharmacists in care homes
Study evaluates the effectiveness and safety of prescribing pharmacists in care homes
INNA-051 nasal spray accelerates respiratory virus clearance in phase 2 trial
INNA-051 nasal spray accelerates respiratory virus clearance in phase 2 trial
Reduced capsaicin cough reflex sensitivity linked to hospitalisation in COPD
Reduced capsaicin cough reflex sensitivity linked to hospitalisation in COPD
CT biomarker model enables prediction of COPD exacerbations
CT biomarker model enables prediction of COPD exacerbations
Continued exercise for 10 years linked to reduced risk type 2 diabetes
Continued exercise for 10 years linked to reduced risk type 2 diabetes
Analysis finds vitamin D supplementation potentially beneficial for type 2 diabetes
Analysis finds vitamin D supplementation potentially beneficial for type 2 diabetes
MHRA approves Rinvoq for moderate to severe Crohn’s disease
MHRA approves Rinvoq for moderate to severe Crohn’s disease
EU approves dapagliflozin across all ejection fractions in heart failure
EU approves dapagliflozin across all ejection fractions in heart failure
Predicting frequent emergency care use with machine learning no better than existing models
Predicting frequent emergency care use with machine learning no better than existing models
Colchicine reduces biomarkers of myocardial injury after non-CABG surgery
Colchicine reduces biomarkers of myocardial injury after non-CABG surgery
Emergency Department diabetic screening program identifies undiagnosed patients
Emergency Department diabetic screening program identifies undiagnosed patients


Popular articles

Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction
Ide-cel provides 51% reduction in the risk of progression or death in R/R multiple myeloma
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora